Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells

被引：22

作者：

Munoz-Gamez, J. A. ^{[1
]}

Quiles-Perez, R. ^{[2
]}

Ruiz-Extremera, A. ^{[2
]}

Martin-Alvarez, A. B.

Sanjuan-Nunez, Laura ^{[3
]}

Carazo, A.

Leon, Josefa ^{[2
]}

Oliver, F. J. ^{[4
]}

Salmeron, J. ^{[2
]}

机构：

[1] San Cecilio Univ Hosp, Lab Med Res, Granada 18012, Spain

[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Granada, Spain

[3] Univ Granada, Dept Med, E-18071 Granada, Spain

[4] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain

来源：

CANCER LETTERS | 2011年 / 301卷 / 01期

关键词：

PARP-1; Antineoplastic therapy; Hepatocellular carcinoma; Transcriptional regulation; Cell death; DNA repair; HUMAN HEPATOCELLULAR-CARCINOMA; POLY(ADP-RIBOSE) POLYMERASE; GENE-EXPRESSION; PARP-1; DEFICIENCY; TUMOR; CARCINOGENESIS; MODULATION; ACTIVATION; GROWTH; INJURY;

D O I：

10.1016/j.canlet.2010.10.026

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

The purpose of this study was to investigate whether PARP-1 inhibition sensitizes human liver cancer cell lines to doxorubicin treatment. Both the addition of PARP-1 inhibitor (ANI) and depletion by means of stable siRNA significantly enhanced the growth inhibition induced by the DNA damage agents used. This effect was associated with an accumulation of unrepaired DNA, with a reduction in EGER and Bcl-xL gene expression as well as with positive annexin-V staining. These results provide novel evidence of the direct role of PARP-1 in tumour chemoresistance in relation to its effects on the transcription of key genes involved in tumour survival. (C) 2010 Elsevier Ireland Ltd. All rights reserved.

引用

页码：47 / 56

页数：10

共 37 条

[1]

Modulation of transcription by PARP-1:: Consequences in carcinogenesis and inflammation [J].

Aguilar-Quesada, R. ;

Munoz-Gamez, J. A. ;

Martin-Oliva, D. ;

Peralta-Leal, A. ;

Quiles-Perez, R. ;

Rodriguez-Vargas, J. M. ;

de Almodovar, M. Ruiz ;

Conde, C. ;

Ruiz-Extremera, A. ;

Oliver, F. J. .

CURRENT MEDICINAL CHEMISTRY, 2007, 14 (11) :1179-1187

[2]

Inhibition of poly (ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models [J].

Albert, Jeffrey M. ;

Cao, Carolyn ;

Kim, Kwang Woon ;

Willey, Christopher D. ;

Geng, Ling ;

Xiao, Dakai ;

Wang, Hong ;

Sandler, Alan ;

Johnson, David H. ;

Colevas, Alexander D. ;

Low, Jennifer ;

Rothenberg, Mace L. ;

Lu, Bo .

CLINICAL CANCER RESEARCH, 2007, 13 (10) :3033-3042

[3]

High Poly(Adenosine Diphosphate-Ribose) Polymerase Expression and Poor Survival in Advanced-Stage Serous Ovarian Cancer [J].

Barnett, Jason C. ;

Bean, Sarah M. ;

Nakayama, John M. ;

Kondoh, Eiji ;

Murphy, Susan K. ;

Berchuck, Andrew .

OBSTETRICS AND GYNECOLOGY, 2010, 115 (01) :49-54

[4]

Dysregulation of growth factor signaling in human hepatocellular carcinoma [J].

Breuhahn, K. ;

Longerich, T. ;

Schirmacher, P. .

ONCOGENE, 2006, 25 (27) :3787-3800

[5]

Long-term outcome of resection of large hepatocellular carcinoma [J].

Chen, X. -P. ;

Qiu, F. -Z. ;

Wu, Z. -D. ;

Zhang, Z. -W. ;

Huang, Z. -Y. ;

Chen, Y. -F .

BRITISH JOURNAL OF SURGERY, 2006, 93 (05) :600-606

[6]

DNA-independent PARP-1 activation by phosphorylated ERK2 increases EIk1 activity: A link to histone acetylation [J].

Cohen-Armon, Malka ;

Visochek, Leonid ;

Rozensal, Dana ;

Kalal, Adi ;

Geistrikh, Ilona ;

Klein, Rodika ;

Bendetz-Nezer, Sarit ;

Yao, Zhong ;

Seger, Rony .

MOLECULAR CELL, 2007, 25 (02) :297-308

[7]

Shock, inflammation and PARP [J].

Cuzzocrea, S .

PHARMACOLOGICAL RESEARCH, 2005, 52 (01) :72-82

[8]

Hepatocellular carcinoma pathogenesis: from genes to environment [J].

Farazi, Paraskevi A. ;

DePinho, Ronald A. .

NATURE REVIEWS CANCER, 2006, 6 (09) :674-687

[9]

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [J].

Farmer, H ;

McCabe, N ;

Lord, CJ ;

Tutt, ANJ ;

Johnson, DA ;

Richardson, TB ;

Santarosa, M ;

Dillon, KJ ;

Hickson, I ;

Knights, C ;

Martin, NMB ;

Jackson, SP ;

Smith, GCM ;

Ashworth, A .

NATURE, 2005, 434 (7035) :917-921

[10]

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers. [J].

Fong, Peter C. ;

Boss, David S. ;

Yap, Timothy A. ;

Tutt, Andrew ;

Wu, Peijun ;

Mergui-Roelvink, Marja ;

Mortimer, Peter ;

Swaisland, Helen ;

Lau, Alan ;

O'Connor, Mark J. ;

Ashworth, Alan ;

Carmichael, James ;

Kaye, Stan B. ;

Schellens, Jan H. M. ;

de Bono, Johann S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) :123-134

← 1 2 3 4 →